AI has become a central element of Cadence Design Systems’ broader ‘Intelligent System Design’ strategy, as NE discovers ...
U.S. pharma giant Eli Lilly LLY has just thrust the rapidly evolving field of artificial intelligence (AI)-driven drug discovery into the spotlight, signing a landmark deal worth up to $2.75 billion ...
Academics, educators, and policymakers are increasingly aware of the enormous opportunities AI offers, while also recognizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results